Gefitinib Pharmascience

Gefitinib is an oral medication used to treat certain types of cancer. This Pharmascience product is designed for targeted therapy, offering a convenient treatment option for eligible patients.

Gefitinib is primarily used in the treatment of non-small cell lung cancer (NSCLC) that has specific genetic features. It works by targeting and inhibiting the growth of cancer cells, making it a key component in personalized cancer therapy. Patients often wonder, 'What is Gefitinib used for?'—it is typically prescribed for advanced or metastatic NSCLC with EGFR mutations.

Common effects of Gefitinib may include skin rash, diarrhea, and appetite loss. Some users also report fatigue and dry skin. These effects can vary in intensity and duration, depending on individual responses to the medication.

Gefitinib should be handled with care, especially by pregnant women or those planning to become pregnant. It is important to follow healthcare provider instructions and report any severe or persistent side effects. Always store the medication as directed to maintain its efficacy.

Gefitinib may interact with certain medications, including those that induce or inhibit liver enzymes. It is advisable to inform your healthcare provider about all medications you are taking to avoid potential interactions. Additionally, avoid grapefruit products, as they can affect the metabolism of Gefitinib.